| Literature DB >> 28185009 |
Philippe Gorphe1, Yungan Tao2, Pierre Blanchard2, Caroline Even3, Antoine Moya-Plana3, Haïtham Mirghani3, France Nguyen2, Stéphane Temam3, François Janot3.
Abstract
To assess the relationship between the locoregional disease-free interval after treatment of the primary tumor and survival after a recurrence in patients with laryngeal carcinoma. We retrospectively investigated patients treated in our Cancer Center for a laryngeal cancer who subsequently developed a locoregional recurrence and were followed up until death. Post-recurrence survival was defined as the time from the locoregional recurrence to death. One hundred and twenty-three patients were included. Median post-recurrence survival was 7 months. The locoregional disease-free interval (LRDFI) after treatment of the primary was weakly correlated with post-recurrence survival (r = 0.210, p = 0.020). A LRDFI cut-off of 12 months was a significant prognostic factor (p = 0.005; median, 5 months, 95% CI: 2.239-6.761, vs 10 months, 95% CI: 7.270-12.730). The time to locoregional recurrence in laryngeal cancer was a prognostic factor correlated with post-recurrence survival. Locoregional failure within the first year after treatment of the primary tumor was associated with an unfavorable prognosis.Entities:
Keywords: Disease-free interval; Laryngeal cancer; Locoregional recurrence; Survival
Mesh:
Year: 2017 PMID: 28185009 DOI: 10.1007/s00405-017-4473-3
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 2.503